Ito Yuya, Takazono Takahiro, Obase Yasushi, Fukahori Susumu, Ashizawa Nobuyuki, Hirayama Tatsuro, Tashiro Masato, Yamamoto Kazuko, Imamura Yoshifumi, Hosogaya Naoki, Fukushima Chizu, Morinaga Yoshitomo, Yanagihara Katsunori, Izumikawa Koichi, Mukae Hiroshi
Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan.
Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
J Fungi (Basel). 2022 Apr 23;8(5):436. doi: 10.3390/jof8050436.
Allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) are important fungal infections caused by Aspergillus species. An overlap of ABPA and CPA has been reported; therefore, it is critical to determine whether the main pathology is ABPA or CPA and whether antifungals are required. In this study, we investigated whether the serum cytokine profile is useful for understanding the pathology and for differentiating between these diseases. We compared the various serum cytokine levels among healthy subjects and patients diagnosed with asthma, ABPA, or CPA at Nagasaki University Hospital between January 2003 and December 2018. In total, 14 healthy subjects, 19 patients with asthma, 11 with ABPA, and 10 with CPA were enrolled. Interleukin (IL) -5 levels were significantly higher in patients with ABPA than in those with CPA, and IL-33 and tumor necrosis factor (TNF) levels were significantly higher in patients with CPA than in those with asthma (p < 0.05, Dunn’s multiple comparison test). The sensitivity and specificity of the IL-10/IL-5 ratio (cutoff index 2.47) for diagnosing CPA were 70% and 100%, respectively. The serum cytokine profile is useful in understanding the pathology of ABPA and CPA, and the IL-10/IL-5 ratio may be a novel supplemental biomarker for indicating the pathology of CPA.
变应性支气管肺曲霉病(ABPA)和慢性肺曲霉病(CPA)是由曲霉属真菌引起的重要真菌感染。已有报道ABPA和CPA存在重叠;因此,确定主要病理是ABPA还是CPA以及是否需要抗真菌药物至关重要。在本研究中,我们调查了血清细胞因子谱是否有助于理解病理以及区分这些疾病。我们比较了2003年1月至2018年12月期间在长崎大学医院的健康受试者以及被诊断为哮喘、ABPA或CPA的患者的各种血清细胞因子水平。总共纳入了14名健康受试者、19名哮喘患者、11名ABPA患者和10名CPA患者。ABPA患者的白细胞介素(IL)-5水平显著高于CPA患者,CPA患者的IL-33和肿瘤坏死因子(TNF)水平显著高于哮喘患者(p<0.05,邓恩多重比较检验)。IL-10/IL-5比值(截断指数2.47)诊断CPA的敏感性和特异性分别为70%和100%。血清细胞因子谱有助于理解ABPA和CPA的病理,IL-10/IL-5比值可能是一种用于指示CPA病理的新型补充生物标志物。